2017
Current treatment of central retinal artery occlusion: a national survey
Youn TS, Lavin P, Patrylo M, Schindler J, Kirshner H, Greer DM, Schrag M. Current treatment of central retinal artery occlusion: a national survey. Journal Of Neurology 2017, 265: 330-335. PMID: 29236169, DOI: 10.1007/s00415-017-8702-x.Peer-Reviewed Original ResearchMeSH KeywordsDisease ManagementFemaleHemodilutionHospitals, TeachingHumansMaleNeuroimagingRetinal Artery OcclusionRisk FactorsSurveys and QuestionnairesThrombolytic TherapyUnited StatesConceptsRetinal artery occlusionAnterior chamber paracentesisArtery occlusionEmergency departmentTreatment teamCentral retinal artery occlusionPrimary treating physicianFirst-line treatmentVascular risk factorsPreferred initial treatmentHyperbaric oxygen therapyPopulation of patientsMagnetic resonance imagingNational surveyCRAO casesCardiovascular riskIntravenous fibrinolysisVascular neurologyAcute managementAcute treatmentOxygen therapySystemic fibrinolysisTreating physicianInitial treatmentInflammatory state
2015
Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis
Schrag M, Youn T, Schindler J, Kirshner H, Greer D. Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis. JAMA Neurology 2015, 72: 1148-1154. PMID: 26258861, DOI: 10.1001/jamaneurol.2015.1578.Peer-Reviewed Original ResearchConceptsCentral retinal artery occlusionRetinal artery occlusionSystemic fibrinolytic therapyVisual acuity outcomesPatient-level dataNatural history groupConservative treatmentFibrinolytic therapyArtery occlusionAcuity outcomesPatient-Level Meta-AnalysisIntravenous fibrinolytic therapyAnterior chamber paracentesisAbsolute risk reductionOutcome of treatmentNatural history studiesTissue plasminogen activatorRandom-effects modelRelevant review articlesWeb of ScienceFibrinolysis treatmentConservative therapyRetinal ischemiaVisual outcomeConservative modalities
2012
Acute Central Retinal Artery Occlusion Treated with Intravenous Recombinant Tissue Plasminogen Activator
Nowak RJ, Amin H, Robeson K, Schindler JL. Acute Central Retinal Artery Occlusion Treated with Intravenous Recombinant Tissue Plasminogen Activator. Journal Of Stroke And Cerebrovascular Diseases 2012, 21: 913.e5-913.e8. PMID: 22349707, DOI: 10.1016/j.jstrokecerebrovasdis.2012.01.003.Peer-Reviewed Original ResearchConceptsCentral retinal artery occlusionAcute central retinal artery occlusionIntravenous recombinant tissue plasminogen activatorRecombinant tissue plasminogen activatorRetinal artery occlusionTissue plasminogen activatorMacular edemaArtery occlusionSymptom onsetLeft eyeVisual acuityRt-PACases of CRAOAcute ischemic cerebral strokePlasminogen activatorIntravenous rt-PALeft afferent pupillaryIschemic cerebral strokeProspective clinical trialsEffective therapeutic optionCherry-red spotRight-handed manMinimal visual acuityCurrent literatureAfferent pupillary